ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,815.03
      0.61%
      US Tech 100
      19,734.40
      0.00%
      Dow Jones
      42,863.86
      0.97%
      Brent Oil
      77.525
      0.08%
      Bitcoin
      64,549.55
      2.70%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Biora Therapeutics Inc (BIOR) Quote

      Biora Therapeutics Inc

      Biora Therapeutics Inc (BIOR)

      NASDAQ
      0.5518
      0.00
      (0.00%)
      Closed October 14 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.5518
      Bid
      0.5503
      Ask
      0.56
      Volume
      -
      0.00 Day's Range 0.00
      0.47 52 Week Range 2.7129
      Market Cap
      20.124M
      Previous Close
      0.5518
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      201,140
      Shares Outstanding
      36,469,088
      Dividend Yield
      -
      PE Ratio
      -0.16
      Earnings Per Share (EPS)
      -3.4
      Revenue
      4k
      Net Profit
      -124.12M

      About Biora Therapeutics Inc

      Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.bicara.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Biora Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOR. The last closing price for Biora Therapeutics was $0.55. Over the last year, Biora Therapeutics shares have traded in a share price range of $ 0.47 to $ 2.7129.

      Biora Therapeutics currently has 36,469,088 shares outstanding. The market capitalization of Biora Therapeutics is $20.12 million. Biora Therapeutics has a price to earnings ratio (PE ratio) of -0.16.

      Ask ADVFN Intelligence (AI)

      BIOR Latest News

      More News

      Form PRE 14A - Other preliminary proxy statements

      October 11 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 11 2024
      Edgar (US Regulatory)

      Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

      October 09 2024
      Edgar (US Regulatory)

      Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium

      SAN DIEGO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will present...

      October 07 2024
      GlobeNewswire Inc.

      Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024

      SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced an upcoming poster presentation at...

      September 30 2024
      GlobeNewswire Inc.

      Form DEF 14A - Other definitive proxy statements

      September 16 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      September 13 2024
      Edgar (US Regulatory)

      Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

      September 13 2024
      Edgar (US Regulatory)

      Biora Therapeutics Achieves ISO 13485 Certification

      SAN DIEGO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it has been awarded ISO 13485:2016...

      September 09 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      September 05 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0122-2.163120567380.5640.58010.492487420.54788301CS
      4-0.1082-16.39393939390.660.6790.472515750.55457967CS
      12-0.1282-18.85294117650.680.710.472011400.61265388CS
      26-0.1215-18.04544779440.67330.790.472302580.64024721CS
      52-1.3482-70.95789473681.92.71290.473809871.05495705CS
      156-20.9482-97.433488372121.528.750.478985319.81536126CS
      260-20.9482-97.433488372121.528.750.478985319.81536126CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 11.79
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 64.67
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.05
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9404
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 11.79
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 64.67
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.05
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9404
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 11.79
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 64.67
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.05
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9404
      (0.00%)
      		0

      BIOR Discussion

      View Posts
      The Night Stalker The Night Stalker 5 months ago
      nice
      👍️0
      Arnold25764 Arnold25764 5 months ago
      Any possible catalyst here?
      👍️0
      Monksdream Monksdream 6 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 6 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 7 months ago
      BIOR 10Q due 3/26
      👍️0
      Monksdream Monksdream 7 months ago
      BIOR under $2
      👍️0
      glenn1919 glenn1919 7 months ago
      BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 8 months ago
      BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 10 months ago
      BIOR new 52 week low
      👍️0
      Monksdream Monksdream 10 months ago
      BOIR new 52 week low
      👍️0
      Monksdream Monksdream 10 months ago
      BIOR new 52 week low
      👍️0
      TheFinalCD TheFinalCD 10 months ago
      https://finviz.com/quote.ashx?t=BIOR&p=d

      https://dilutiontracker.com/app/search/BIOR
      👍️0
      Awl416 Awl416 10 months ago
      Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
      👍️0
      retireat40 retireat40 12 months ago
      Looked good this morning at 2.66 but a crappy close.
      👍️0
      Monksdream Monksdream 1 year ago
      BIOR Barchart Bottom 100
      Biora Therapeutics Inc NASDAQ: BIOR



      GoSymbol lookup
      Health Care : Biotechnology | Small Cap ValueCompany profile
      Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
      👍️0

      Your Recent History

      NASDAQ
      BIOR
      Biora Therapeutics
      Delayed Upgrade Clock